Anti-SSA and Anti-dsDNA Autoantibodies in Rheumatoid Arthritis Patients and their Association with Disease Severity: A Case-Control Study in Kerbala Province

Farhan LO, Khaleel F M, Taha E M. Human β-defensin 2 as a novel diagnostic marker of Iraqi patients with rheumatoid arthritis. Iraqi J Sci. 2023;64(5):2143-2135. doi: 10.24996/ijs.2023.64.5.3. DOI: https://doi.org/10.24996/ijs.2023.64.5.3

Wu CY, Yang HY, Luo SF, Lai JH. From rheumatoid factor to anti-citrullinated protein antibodies and anti-carbamylated protein antibodies for diagnosis and prognosis prediction in patients with rheumatoid arthritis. Int J Mol Sci. 2021;22(2):686. doi: 3390/ijms22020686. DOI: https://doi.org/10.3390/ijms22020686

Mathkhor AJ, Abdullah AH, Khoudhairy A.S. Demographic, clinical, and serological features of Iraqi patients with rheumatoid arthritis: evaluation of 470 patients. Int J Clin Rheumatol. 2021;16(3):99-103.

Eloff E, Martinsson K, Ziegelasch M, Cedergren J, Reckner, Skogh T, et al. Autoantibodies are major predictors of arthritis development in patients with anti-citrullinated protein antibodies and musculoskeletal pain. Scand J Rheumatol. 2021;50(3):189-197. doi: 10.1080/03009742.2020.1818820. DOI: https://doi.org/10.1080/03009742.2020.1818820

Aiman AQ, Nesrin M, Amal A, Nassar AD. A new tool for early diagnosis of rheumatoid arthritis using combined biomarkers; synovial MAGE-1 mRNA and serum anti-CCP and RF. Pan Afr Medi J. 2020;36(1). doi: 10.11604/pamj.2020.36.270.21827. DOI: https://doi.org/10.11604/pamj.2020.36.270.21827

Alattabi A. Sensitivity and specificity of rheumatoid factor and anti-cyclic citrullinated protein antibody positivity in patients with rheumatoid arthritis in Kerbala city. Kerbala J Pharm Sci. 2016;11:110-115.

Belakova G, Manka V, Zanova E, Racay P. Benefits of anticitrullinated peptides examination in rheumatoid arthritis. Nigerian J Clin Pract. 2018;21(10):1380-1383. doi: 10.4103/njcp.njcp_411_17.

Di Matteo A, Mankia, K, Duquenne L, Mahler M, Corscadden D, Mbara K, et al. Third‐generation anti–cyclic citrullinated peptide antibodies improve prediction of clinical arthritis in individuals at risk of rheumatoid arthritis. Arthr Rheumatol. 2020;72(11):1820-1828. doi: 10.1002/art.41402. DOI: https://doi.org/10.1002/art.41402

Franceschini F, Cavazzana I. Anti-ro/ssa and la/ssb antibodies. Autoimmunity. 2005;38(1):55-63. doi: 10.1080/08916930400022954. DOI: https://doi.org/10.1080/08916930400022954

Hajiabbasi A, Masooleh IS, Alizadeh Y, Banikarimi AS. Secondary Sjogren's syndrome in 83 patients with rheumatoid arthritis. Acta Medica Iranica. 2016;54(7):448-453.

Lazzerini PE, Laghi-Pasini F, Boutjdir M, Capecchi PL. Anti-Ro/SSA antibodies and the autoimmune long-QT syndrome. Front Med. 2021;8:730161. doi: 10.3389/fmed.2021.730161. DOI: https://doi.org/10.3389/fmed.2021.730161

Cavazzana I, Franceschini F, Quinzanini M, Manera C, Del Papa N, Maglione W, et al. Anti-Ro/SSA antibodies in rheumatoid arthritis: clinical and immunologic associations. Clin Exp Rheumatol. 2006;24(1):59.

Abdulsattar SA, Mohammed AA, Mustafa MN. Antibodies of double stranded deoxyribonucleic acid and antinuclear in patients with rheumatoid arthritis: Comparison study of seropositive and seronegative. Indian J Forens Med Toxicol. 2020;14(4):3504-3510. doi: 10.37506/ijfmt.v14i4.12169. DOI: https://doi.org/10.37506/ijfmt.v14i4.12169

Cartas US, Martínez Larrarte JP, Prada Hernández DM, Gómez Morejón JA, Valdés González JL, Molinero Rodríguez C. Rhupus syndrome. A rare combination. Revista Colombiana de Reumatología. 2017;24(4):237-241. doi: 10.1016/j.rcreue.2017.05.004. DOI: https://doi.org/10.1016/j.rcreue.2017.05.004

Hussein RH, MezherAl-Rayahi IA, Taha K. Rheumatoid factor isotypes in a sample of Iraqi rheumatoid arthritis patients. J Glob Pharma Technol. 2018;10:141-145.

Jwad RK, Kadhim, JD, Alosami, MHM, Shareef GL. Medication-related burden among Iraqi patients with rheumatoid arthritis: An observational study. F1000Research, 2022;11(1047):1047. doi: 10.12688/f1000research.125446.1. DOI: https://doi.org/10.12688/f1000research.125446.1

Henze L, Schwinge D, Schramm C. The effects of androgens on T cells: clues to female predominance in autoimmune liver diseases? Front Immunol. 2020;11:1567. doi: 10.3389/fimmu.2020.01567. DOI: https://doi.org/10.3389/fimmu.2020.01567

Ahmed H, Al-Sadoon TA. The clinical aspect of overweight on rheumatoid arthritis and disease activity. J Biotechnol Res Center., 2019;13(2):10-16. DOI: https://doi.org/10.24126/jobrc.2019.13.2.576

Al-Ani MM. Comparison between anti-filaggrin, anti-RA33 and anti-cyclic citrullinated peptide antibodies in the diagnosis of rheumatoid arthritis in iraqi patients. Iraqi J Comm Med. 2013;3:258-261.

Ali QR, Alani QM, Abdallha NH. Evaluate the prevalence of CCP and RF antibodies as a marker for diagnosis and progression of Rheumatoid Arthritis disease and assess the prevalence of HCV in RA patients. J Univ Anbar Pure Sci. 2013;2. doi: 10.37652/juaps.2013.84963. DOI: https://doi.org/10.37652/juaps.2013.84963

Alattabi AS, AL-Hasnawi ATN, AL-Hasnawi SMJ. Anti-RA33 antibody is more sensitive than anti-citrullinated protein antibody in diagnosis of rheumatoid arthritis. J Cardiovasc Dis Res. 2020;11(2):20-24. doi: 10.31838/jcdr.2020.11.02.05.

Al-Taee MM, Mohmood DI, Muhammed MM. Determining levels of rheumatoid factor (RF) and C-reactive protein (CRP) in a blood sample of Iraqi patients with rheumatoid arthritis (RA). Al-Nisour J Med Sci. 2019;1(1):133-139.

Ali AI, Jasim M. Performance of anticyclic citrullinated peptide antibodies versus rheumatoid factor in diagnosis of rheumatoid arthritis. Diyala J Med. 2011;1(1):81-90.

Abd-Ali AH. Correlation between Anti cyclic-citrullinated-eptide and rheumatoid Factor Antibodies “levels in” Patients with from Rheumatoid Arthritis. J Univ Babylon Pure Appl Sci. 2018;26(2):91-98.

Taha EA, Moustafa SR. Combination of novel and tradition biomarkers to enhance diagnostic sensitivity and specificity for early diagnosis of rheumatoid arthritis and seronegative rheumatoid arthritis. Zanco J Med Sci. 2019;23(2):238-249. doi: 10.15218/zjms.2019.031. DOI: https://doi.org/10.15218/zjms.2019.031

Khater ES, Al Sheik MF. Clinical implications of autoantibodies to extractable nuclear antigens in rheumatoid arthritis patients in tertiary care hospital in Riyadh, Saudi Arabia. Egypt J Immunol. 2022;29(2):87-95. doi: 10.55133/eji.290210. DOI: https://doi.org/10.55133/eji.290210

Shakiba Y, Koopah S, Jamshidi AR, Amirzargar AA, Massoud A, Kiani A, et al. Anti-cyclic citrullinated peptide antibody and rheumatoid factor isotypes in Iranian patients with rheumatoid arthritis: evaluation of clinical value and association with disease activity. Iran J Allergy Asthma Immunol. 2014;13(3):147-156.

Kim H, Cho S, Kim HW, Han J, Kim Y, Hwang K, et al. The prevalence of Sjögren's syndrome in rheumatoid arthritis patients and their clinical features. J Korean Med Sci. 2020;35(45):e369. doi: 10.3346/jkms.2020.35.e369. DOI: https://doi.org/10.3346/jkms.2020.35.e369

Yang H, Bian S, Chen H, Wang L, Zhao L, Zhang X, et al. Clinical characteristics and risk factors for overlapping rheumatoid arthritis and Sjögren’s syndrome. Sci Rep. 2018;8(1):6180. doi: 10.1038/s41598-018-24279-1. DOI: https://doi.org/10.1038/s41598-018-24279-1

Waki D, Tamai H, Yokochi R, Kido T, Yagyu Y, Yanai R, et al. Effects of anti-SSA antibodies on the response to methotrexate in rheumatoid arthritis: A retrospective multicenter observational study. Plos One. 2022;17(7):e0271921. doi: 10.1371/journal.pone.0271921. DOI: https://doi.org/10.1371/journal.pone.0271921

Abid Fatehi HI. An immunoserological study of rheumatological diseases with an autoimmune pathogenesis. Thesis, College of Medicine, University of Mousel. 2007. pp. 1–172.

Damián-Abrego GN, Cabiedes J, Cabral AR. Anti-citrullinated peptide antibodies in lupus patients with or without deforming arthropathy. Lupus. 2008;17(4):300-304. doi: 10.1177/0961203307087613. DOI: https://doi.org/10.1177/0961203307087613

Oglah AA, Mohammed KIA, Alosami MH. A comparative study of serum amyloid A2 with anti-cyclic citrullinated peptide antibody in the prognosis of a group of rheumatoid arthritis patients in Iraq. J Fac Med Baghdad. 2022;64(3):153-158. doi: 10.32007/jfacmedbagdad.6431947. DOI: https://doi.org/10.32007/jfacmedbagdad.6431947

Hassoon HJ, Jasim WE, Abbas AAH. The Evaluation of some biomarkers according to rheumatoid factor in early diagnosis of rheumatoid arthritis from Iraqi patients. Iraqi J Sci. 2020;61:2196-2203. doi: 10.24996/ijs.2020.61.9.6. DOI: https://doi.org/10.24996/ijs.2020.61.9.6

Al-Ubaidi AH, Al-Ani MM, Al-Bidri KZ. Comparism between anti-RA33, anti-CCP antibodies and rheumatoid factor in the diagnosis of rheumatoid arthritis in Iraqi patients. J Fac Med Baghdad. 2013;55(1):64-67. doi: 10.32007/jfacmedbagdad.551672.

J Hasony H, Abd-AlJalel Badran H. Diagnostic value of anti-peptidylarginine deiminase type 4 (padi-4) and anti-citrullinated peptide antibodies (ACCP) in Iraqi patients with rheumatoid arthritis. Basrah J Surgery. 2014;20(1):39-46. doi: 10.33762/bsurg.2014.91009. DOI: https://doi.org/10.33762/bsurg.2014.91009

Fawzy RM, Said EA, Mansour AI. Association of neutrophil to lymphocyte ratio with disease activity indices and musculoskeletal ultrasound findings in recent onset rheumatoid arthritis patients. Egypt Rheumatol. 2017;39(4):203-206. doi: 10.1016/j.ejr.2017.05.001. DOI: https://doi.org/10.1016/j.ejr.2017.05.001

Gassid AA, Daoud MS, Al-Osami MH. Serum anti-cyclic citrullinated peptide (Anti_CCP) antibody level in rheumatoid arthritic patients with and without nodal osteoarthritis. Iraqi Postgrad Med J. 2012;11(2):151-156.

Zaccardelli A, Friedlander HM, Ford JA, Sparks JA. Potential of lifestyle changes for reducing the risk of developing rheumatoid arthritis: is an ounce of prevention worth a pound of cure? Clin Ther. 2019;41(7):1323-1345. doi: 10.1016/j.clinthera.2019.04.021. DOI: https://doi.org/10.1016/j.clinthera.2019.04.021

Zanlorenzi L, Azevedo PDO, Silva MB, Skare T. Anti-Ro antibodies in rheumatoid arthritis. Acta Reumatol Port. 2012;37:149-152.

Al-Mughales JA. Immunodiagnostic significance of anti-RA33 autoantibodies in Saudi patients with rheumatoid arthritis. J Immunol Res. 2015;2015:604305. doi: 10.1155/2015/604305. DOI: https://doi.org/10.1155/2015/604305

Shpatz R, Braun-Moscovici Y, Balbir-Gurman A. ACPA Antibodies titer at the time of rheumatoid arthritis diagnosis is not associated with disease severity. Isr Med Assoc J. 2021;23(10):646-650.